Riskpilot← Back to searchSign inGet full accessKLB Läkartjänst AB
ABActiveOrg 5568938848Grönegatan 8 AMedical specialists activities · NACE 8622Est. 20122 employees
Revenue 2025
SEK 3M
+5% vs 2024
EBITDA margin
-1.3%
-1% vs 2024
Equity ratio
38.3%
Financial strength
Net profit 2025
SEK 297K
-23% vs 2024
| Revenue | SEK 3M | +5% |
| EBITDA | SEK -38K | -1% |
| Net profit | SEK 297K | -23% |
| Total assets | SEK 4,7M | -51% |
| Equity | SEK 1,8M | -71% |
| Employees | 2 | — |
Legal name
KLB Läkartjänst AB
Org number
5568938848
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 maj 2012
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom hälso- och sjukvårdssektorn.
Address
Grönegatan 8 A
Email
slottsstaden1@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 390 | 5 678 | 4 661 | 2 821 | 2 963 |
| Staff expenses | — | — | — | −1 467 | — |
| EBITDA | 2 271 | 1 870 | 1 282 | −37 | −38 |
| Depreciation & amort. | −219 | −219 | −219 | −219 | −175 |
| EBIT | 2 052 | 1 651 | 1 063 | −256 | −213 |
| Net financials | −1 | −1 | 36 | 255 | 115 |
| Profit before tax | 1 815 | 1 391 | 1 165 | 516 | 398 |
| Tax | −395 | −296 | −265 | −132 | −101 |
| Net profit | 1 420 | 1 095 | 900 | 383 | 297 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 223 | 10 340 | 10 204 | 9 465 | 4 663 |
| Equity | 5 196 | 5 792 | 6 192 | 6 075 | 1 786 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 449 | 713 | 243 | 137 | 119 |
| Total debt | 449 | 713 | 243 | 137 | 119 |
EBITDA margin
-1.3%
This company
15.8%
Market median
-108% vs market
20212025
Equity ratio
38.3%
This company
38.2%
Market median
+0% vs market
20212025
Return on equity
16.6%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
10.0%
This company
8.1%
Market median
+23% vs market
20212025
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20212025
Debt / equity
1.61×
This company
0.62×
Market median
-160% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CM Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLB Läkartjänst AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Magnus Haak | Chief Auditor | 0 companies |
| Jonathan Henning Brandt | Deputy Board Member | 0 companies |
| Katarina Elisabeth Brandt | Board of Directors | 0 companies |
| Lars Valter Brandt | Board of Directors | 0 companies |